Medpace Holdings Inc (NASDAQ: MEDP) has a higher price-to-earnings ratio of 21.20x compared to its average ratio. MEDP has 36-month beta value of 1.51. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 9 as “hold,” and 0 as “sell.”
The public float for MEDP is 24.48M, and currently, short sellers hold a 5.69% ratio of that float. The average trading volume of MEDP on April 22, 2025 was 438.80K shares.
MEDP) stock’s latest price update
Medpace Holdings Inc (NASDAQ: MEDP)’s stock price has dropped by -7.32 in relation to previous closing price of 288.99. Nevertheless, the company has seen a loss of -12.27% in its stock price over the last five trading days. zacks.com reported 2025-04-21 that Medpace (MEDP) came out with quarterly earnings of $3.67 per share, beating the Zacks Consensus Estimate of $3.06 per share. This compares to earnings of $3.20 per share a year ago.
MEDP’s Market Performance
Medpace Holdings Inc (MEDP) has experienced a -12.27% fall in stock performance for the past week, with a -17.40% drop in the past month, and a -22.93% drop in the past quarter. The volatility ratio for the week is 3.49%, and the volatility levels for the past 30 days are at 5.06% for MEDP. The simple moving average for the last 20 days is -10.51% for MEDP’s stock, with a simple moving average of -22.81% for the last 200 days.
Analysts’ Opinion of MEDP
TD Cowen, on the other hand, stated in their research note that they expect to see MEDP reach a price target of $328. The rating they have provided for MEDP stocks is “Hold” according to the report published on April 14th, 2025.
Leerink Partners gave a rating of “Market Perform” to MEDP, setting the target price at $330 in the report published on March 24th of the current year.
MEDP Trading at -16.03% from the 50-Day Moving Average
After a stumble in the market that brought MEDP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -41.75% of loss for the given period.
Volatility was left at 5.06%, however, over the last 30 days, the volatility rate increased by 3.49%, as shares sank -19.08% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.45% lower at present.
During the last 5 trading sessions, MEDP fell by -12.37%, which changed the moving average for the period of 200-days by -33.63% in comparison to the 20-day moving average, which settled at $299.27. In addition, Medpace Holdings Inc saw -19.39% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MEDP starting from EWALD STEPHEN P, who purchase 2 shares at the price of $326.11 back on Feb 27 ’25. After this action, EWALD STEPHEN P now owns 13,343 shares of Medpace Holdings Inc, valued at $652 using the latest closing price.
Carley Brian T, the Director of Medpace Holdings Inc, sale 4,003 shares at $345.59 during a trade that took place back on Feb 24 ’25, which means that Carley Brian T is holding 26,032 shares at $1,383,397 based on the most recent closing price.
Stock Fundamentals for MEDP
Current profitability levels for the company are sitting at:
- 0.21 for the present operating margin
- 0.31 for the gross margin
The net margin for Medpace Holdings Inc stands at 0.19. The total capital return value is set at 0.45. Equity return is now at value 58.41, with 21.52 for asset returns.
Based on Medpace Holdings Inc (MEDP), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at 4.82. The debt to equity ratio resting at 0.15. The interest coverage ratio of the stock is 46.62.
Currently, EBITDA for the company is 446.87 million with net debt to EBITDA at -1.14. When we switch over and look at the enterprise to sales, we see a ratio of 3.63. The receivables turnover for the company is 7.11for trailing twelve months and the total asset turnover is 1.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.93.
Conclusion
To put it simply, Medpace Holdings Inc (MEDP) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
